AnaptysBio changes fiscal year-end from Dec 31 to June 30, effective July 1, 2026

ANAPTYSBIO, INC

Board approved fiscal year change from December 31 to June 30, effective July 1, 2026.
Company will file a transition report on Form 10-KT for the six-month period Jan 1, 2026 to June 30, 2026.
Quarterly reports will follow new fiscal year, beginning with the quarter ending September 30, 2026.
Change is effective for the company's next fiscal year starting July 1, 2026.

item 5.03

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ANAPTYSBIO, INC: Changed fiscal year-end from December 31 to June 30, effective July 1, 2026 (effective 2026-07-01).

Change: fiscal year change
Effective: 2026-07-01

Exact text from the filing

On May 18, 2026, the Board of Directors of AnaptysBio, Inc. (the “Company”) approved a change in the Company’s fiscal year-end from December 31 to June 30.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

ANAPTYSBIO, INC filing history →

Source: SEC EDGAR

accession 0001193125-26-234419

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.